FENC compared with NRXS: revenue, margins and what each company keeps, and the suppliers and customers both name

FENCFennec Pharmaceuticals Inc.

Mkt capRevenueRevenue

NRXSNeuraxis, Inc

Mkt capRevenueRevenue

Compare

FENCFennec Pharmaceuticals Inc.

NRXSNeuraxis, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

FENCFennec Pharmaceuticals Inc.

10.68▲+1.29%· post 10.68· delayed

Mkt cap$369.6MRevenue$18MQ2 FY26Revenue$45MFY25

NRXSNeuraxis, Inc

6.64▲+0.61%· post 6.64· delayed

After hoursNov 3 '26delayed

Mkt cap$82.9MRevenue$2MQ2 FY26Revenue$4MFY25

Compare

After hoursNov 3 '26delayed

FENCFennec Pharmaceuticals Inc.

NRXSNeuraxis, Inc

10.68▲+1.29%post 10.68delayed

Price

6.64▲+0.61%post 6.64delayed

$369.6M

Mkt cap

$82.9M

Q2 FY26$18M

Revenue

$2MQ2 FY26

FY25$45M

Revenue

$4MFY25

FENC10.68▲+1.29%vsNRXS6.64▲+0.61%After hoursNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NRXS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only FENC 2

—Inpharmusunlistedcustomer

—Norgineunlistedcustomer

Shared 0

No shared counterparties.

Only NRXS 1

—Masimounlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

FENC, solidNRXS, dashed